1. Home
  2. AMBA vs APLS Comparison

AMBA vs APLS Comparison

Compare AMBA & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMBA
  • APLS
  • Stock Information
  • Founded
  • AMBA 2004
  • APLS 2009
  • Country
  • AMBA United States
  • APLS United States
  • Employees
  • AMBA N/A
  • APLS N/A
  • Industry
  • AMBA Semiconductors
  • APLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMBA Technology
  • APLS Health Care
  • Exchange
  • AMBA Nasdaq
  • APLS Nasdaq
  • Market Cap
  • AMBA 3.5B
  • APLS 2.9B
  • IPO Year
  • AMBA N/A
  • APLS 2017
  • Fundamental
  • Price
  • AMBA $93.86
  • APLS $19.88
  • Analyst Decision
  • AMBA Strong Buy
  • APLS Buy
  • Analyst Count
  • AMBA 10
  • APLS 20
  • Target Price
  • AMBA $93.44
  • APLS $33.15
  • AVG Volume (30 Days)
  • AMBA 468.3K
  • APLS 3.1M
  • Earning Date
  • AMBA 11-25-2025
  • APLS 10-30-2025
  • Dividend Yield
  • AMBA N/A
  • APLS N/A
  • EPS Growth
  • AMBA N/A
  • APLS N/A
  • EPS
  • AMBA N/A
  • APLS 0.36
  • Revenue
  • AMBA $348,051,000.00
  • APLS $1,016,397,000.00
  • Revenue This Year
  • AMBA $35.94
  • APLS $25.39
  • Revenue Next Year
  • AMBA $8.00
  • APLS N/A
  • P/E Ratio
  • AMBA N/A
  • APLS $55.70
  • Revenue Growth
  • AMBA 57.91
  • APLS 42.11
  • 52 Week Low
  • AMBA $38.86
  • APLS $16.10
  • 52 Week High
  • AMBA $93.44
  • APLS $35.72
  • Technical
  • Relative Strength Index (RSI)
  • AMBA 64.78
  • APLS 33.80
  • Support Level
  • AMBA $81.26
  • APLS $19.44
  • Resistance Level
  • AMBA $87.77
  • APLS $30.48
  • Average True Range (ATR)
  • AMBA 3.37
  • APLS 1.58
  • MACD
  • AMBA 0.39
  • APLS -0.95
  • Stochastic Oscillator
  • AMBA 100.00
  • APLS 5.48

About AMBA Ambarella Inc.

Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, security cameras, consumer cameras, and industrial and robotic applications. The company's system-on-a-chip designs, based on its proprietary technology platform, are configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

Share on Social Networks: